Comparison Chart: Drugs for Motion Sickness (online only)

The Medical Letter on Drugs and Therapeutics

ONLINE
ONLY
ARTICLE

June 22, 2026

View Complete Issue Table of Contents 2019

PDF: US English

Disclosures & Objectives Disclosures & Objectives

View Complete Issue

Send Article Feedback

Disclosures

Principal Faculty

Jean-Marie Pflomm, Pharm.D., Editor in Chief has disclosed no relevant financial relationships.

Additional Contributor(s)

Corinne Z. Morrison, Pharm.D., Associate Editor has disclosed no relevant financial relationships.

Objective(s)

Upon completion of this activity, the participant will be able to:

Review the efficacy and safety of tradipitant (Nereus) for prevention of motion sickness.

Med Lett Drugs Ther. 2026 Jun 22;68(1757):e98 doi:10.58347/tml.2026.1757g

View the Comparison Chart: Drugs for Motion Sickness
Download PDF: US English

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.